Anhui Wanbang Pharmaceutical Technology Co.,Ltd. (SHE:301520)

China flag China · Delayed Price · Currency is CNY
44.57
-0.45 (-1.00%)
At close: Feb 13, 2026
Market Cap2.95B +17.0%
Revenue (ttm)295.21M -25.2%
Net Income40.84M -62.4%
EPS0.61 -62.4%
Shares Out66.26M
PE Ratio72.69
Forward PEn/a
Dividend0.85 (1.91%)
Ex-Dividend DateJan 24, 2025
Volume612,600
Average Volume990,444
Open45.07
Previous Close45.02
Day's Range44.30 - 45.15
52-Week Range33.45 - 50.83
Beta1.31
RSI53.78
Earnings DateApr 23, 2026

About SHE:301520

Anhui Wanbang Pharmaceutical Technology Co.,Ltd. provides pharmaceutical research and clinical research services in China. It offers clinical trial operations, clinical trial site management, biological sample analysis, and data management and statistical analysis. The company was founded in 2006 and is based in Hefei, China. [Read more]

Industry Commercial Physical and Biological Research
Founded 2006
Employees 362
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301520
Full Company Profile

Financial Performance

In 2024, SHE:301520's revenue was 379.09 million, an increase of 10.91% compared to the previous year's 341.81 million. Earnings were 85.53 million, a decrease of -20.87%.

Financial Statements